Every Form 4 that Viatris Inc. (VTRS) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow VTRS and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full VTRS filings page.
Viatris Inc (VTRS) reported that Chief Administrative and Transformation Officer Andrew Enrietti had restricted stock units (RSUs) and related dividend equivalent units (DEUs) granted on August 15, 2025 vest on August 15, 2026. On that date, 25,134 RSUs and 998.3636 DEUs were converted into common stock. To cover associated tax liabilities on the RSU and DEU settlements, 10,931 and 435 shares of common stock, respectively, were withheld at $16.23 per share. The filing notes that an additional 25,133 RSUs will vest on August 15, 2027 and 25,134 RSUs will vest on August 15, 2028, with DEUs vesting on the same schedule. The Rule 10b5-1 trading plan checkbox was left unchecked.
SIMMONS DAVID S reported acquisition or exercise transactions in this Form 4 filing.
Viatris Inc director David S. Simmons received a grant of 2,362 deferred stock units (DSUs) on June 30, 2026 as compensation for quarterly non-employee director fees, in lieu of cash. The award was valued using the June 30, 2026 closing price of $15.88 per share of Viatris common stock.
Each DSU is fully vested and represents the right to receive one share of Viatris common stock. The DSUs will be settled in shares upon the earliest of Simmons’ termination of service as a non-employee director, his death or disability, or a change in control of Viatris.
Groothuis Leo Frans reported acquisition or exercise transactions in this Form 4 filing.
Viatris Inc. director Leo Frans Groothuis received a grant of 2,756 deferred stock units (DSUs) on June 30, 2026 as compensation in lieu of cash quarterly non-employee director fees. Each DSU is fully vested and represents one share of Viatris common stock, deliverable upon certain future events such as termination of service or a change in control.
Viatris Inc officer Paul Campbell reported selling 50,076 shares of common stock in an open-market transaction at a weighted average price of $16.1711 per share. The sale was made under a pre-arranged Rule 10b5-1 trading plan adopted on March 24, 2026, and Campbell now holds 316,212 shares directly plus 318 shares indirectly through a 401(k) plan.
Viatris Inc Chief Commercial Officer Corinne Le Goff reported routine equity compensation activity tied to previously granted awards. On April 15, 2026, 39,344 restricted stock units and 3,643.8335 related dividend equivalent units vested and were converted into the same number of common shares.
The company withheld 19,067 common shares at $13.86 per share to cover associated tax liabilities, a non-market, tax-withholding disposition rather than an open-market sale. After these transactions, Le Goff holds 107,135 shares of Viatris common stock directly.
Viatris Inc officer Paul Campbell reported an open-market sale of 21,350 shares of common stock at a weighted average price of $13.2805 per share. After this sale, he directly holds 366,288 shares, plus 318 shares held indirectly through a 401(k) plan, indicating he retains a substantial position.
Viatris Inc Chief Commercial Officer Corinne Le Goff reported equity compensation activity centered on restricted stock units and related tax withholding. On March 6, 2026, 44,165 RSUs granted on March 6, 2025 vested and were settled into an equal number of Viatris common shares, along with 2,193 dividend equivalent units that also converted into common stock. To cover tax liabilities on these vestings, 20,561 common shares were withheld at $14.16 per share instead of being retained.
Le Goff also received a new grant of 88,984 RSUs, each representing one future share of common stock. According to the vesting schedule, 29,662 of these RSUs are scheduled to vest on March 6, 2027, and 29,661 are scheduled to vest on each of March 6, 2028 and March 6, 2029, while 44,164 RSUs from the 2025 grant remain scheduled to vest on March 6, 2027 and March 6, 2028. Following these transactions, Le Goff directly holds 83,214 shares of Viatris common stock.
Viatris Inc Chief Financial Officer Theodora Mistras reported several equity-compensation transactions. On March 6, 2026, 41,711 restricted stock units (RSUs) granted on March 6, 2025 vested and were settled into common shares, along with 2,070.6039 related dividend equivalent units (DEUs).
To cover tax obligations on these vestings, 23,067 and 1,146 common shares were withheld at $14.16 per share, so there was no open‑market sale. She also received a new grant of 86,017 RSUs that convert one‑for‑one into Viatris common stock.
Following these transactions, Mistras directly held 70,645 common shares, plus 86,017 RSUs and 4,141 DEUs. The new RSU grant vests in three annual installments: 28,673 units on March 6, 2027 and 28,672 units on each of March 6, 2028 and March 6, 2029.
Maletta Matthew Joseph reported acquisition or exercise transactions in this Form 4 filing.
Viatris Inc reported that Chief Legal Officer Matthew Joseph Maletta received a grant of 59,323 restricted stock units on March 6, 2026. Each RSU represents one share of Viatris common stock. The award vests in three annual tranches: 19,775 RSUs on March 6, 2027 and 19,774 RSUs on each of March 6, 2028 and March 6, 2029. Following this compensation-related grant, Maletta holds 59,323 RSUs directly.
Viatris Inc director Michael Severino reported equity compensation-related transactions in company stock. On March 6, 2026, 25,112 restricted stock units and 918.455 dividend equivalent units vested and were converted into an equal number of Common Stock shares, leaving him with 26,031 common shares directly held after these acquisitions. The same day, he also received a new award of 15,890 restricted stock units, which are scheduled to vest on March 6, 2027. All activity reflects derivative exercises and grants at a price of $0.00 per unit under the Viatris Inc. 2020 Stock Incentive Plan, with no open-market purchases or sales disclosed.
Viatris Inc executive Andrew Enrietti reported routine equity compensation activity involving restricted stock units (RSUs), dividend equivalent units (DEUs) and related tax withholding. On March 6, 2026, 19,169 RSUs granted on March 6, 2025 vested and were exercised into 19,169 shares of common stock, and 951.6215 DEUs were likewise exercised into 951.6215 shares.
To cover tax liabilities from these vestings, 8,337 and 415 shares of common stock were withheld at $14.16 per share, which is a non‑market disposition rather than an open‑market sale. After these transactions, Enrietti directly held 219,677 shares of Viatris common stock.
He also received a new award of 60,435 RSUs on March 6, 2026, each representing one share of common stock, scheduled to vest in three equal installments of 20,145 RSUs on March 6 of 2027, 2028 and 2029, in addition to remaining unvested RSUs and associated DEUs from the 2025 grant.
PARRISH MARK W reported acquisition or exercise transactions in this Form 4 filing.
Viatris Inc director Mark W. Parrish reported equity compensation activity involving restricted stock units and related common shares. Previously granted RSUs and dividend equivalent units vested into 24,834.4921 shares of common stock on March 6, 2026, and he received a new award of 15,890 RSUs that will vest on March 6, 2027. Following these transactions, he directly holds 165,230 shares of common stock and 15,890 unvested RSUs.
Viatris Inc executive Paul Campbell reported equity compensation activity and related tax withholding in company stock. On March 6, 2026, 27,603 restricted stock units (RSUs) granted on March 6, 2025 vested and were settled into an equal number of common shares, along with 1,370.6231 dividend equivalent units (DEUs) that had accrued on those RSUs.
To cover tax liabilities on these vestings, 12,088 and 601 shares of common stock were withheld at $14.16 per share. Campbell also received a new grant of 56,727 RSUs on March 6, 2026, which will vest in three equal installments of 18,909 RSUs on each of March 6, 2027, March 6, 2028, and March 6, 2029. Following these transactions, he holds 387,638 shares of common stock directly and 318 shares indirectly through a 401(k) plan.
Viatris Inc director MARK RICHARD A reported compensation-related equity activity. On March 6, 2026, previously granted restricted stock units and related dividend equivalent units were exercised, delivering a total of about 24,834 shares of common stock as they vested in full.
The filing also shows a new award of 15,890 restricted stock units, each representing one future Viatris share, scheduled to vest on March 6, 2027. Following these transactions, the director directly holds 116,145 Viatris common shares. All visible derivative awards tied to this filing have now been converted into common stock.
Viatris Inc Chief Executive Officer Scott Andrew Smith reported routine equity compensation activity. On March 6, 2026, 124,519 restricted stock units (RSUs) and 6,181.4237 dividend equivalent units (DEUs) were exercised into common stock, increasing his directly held share count to 1,329,326 shares.
To cover tax liabilities on these vestings, 48,999 and 2,433 shares of common stock were withheld at $14.1600 per share, which are non‑market dispositions. Smith also received a new grant of 256,074 RSUs, scheduled to vest in three equal installments of 85,358 units on March 6 of 2027, 2028, and 2029, and continues to hold 12,362 DEUs tied to earlier awards.
Viatris Inc director Melina E. Higgins reported routine equity compensation activity. On March 6, 2026, she exercised restricted stock units and related dividend equivalent units into a total of 24,834.4921 shares of common stock, reflecting previously vested awards under the company’s stock incentive plan.
On the same date, she received a new grant of 15,890 restricted stock units that will vest on March 6, 2027. Following these transactions, she directly holds 146,048 shares of Viatris common stock and has an additional 74,000 shares reported as indirectly owned through her spouse. These entries are compensation-related acquisitions, not open-market purchases or sales.
Viatris Inc director David S. Simmons reported compensation-related equity activity and small prior share purchases. On March 6, 2026, 22,820 restricted stock units and 523.0399 dividend equivalent units vested and were settled into 23,344 shares of common stock, with fractional shares rounded up under the RSU award terms. On the same date, he received a new grant of 15,890 restricted stock units that will vest on March 6, 2027, each RSU representing one common share.
The filing also shows earlier open-market purchases by family trusts associated with Simmons in 2025, totaling 499 shares of common stock at prices around $10.42 per share. According to the footnotes, these trust purchases were executed by investment advisors in managed accounts designed to mirror certain index funds.
Viatris Inc director Leo Frans Groothuis reported routine equity compensation activity. Restricted stock units and related dividend equivalent units that were previously granted vested and were exercised into common stock on March 6, 2026, with a portion of the resulting shares withheld to cover tax liabilities at $14.16 per share.
On the same date, Groothuis received a new grant of 15,890 restricted stock units, each representing one future share of Viatris common stock that will vest on March 6, 2027. After these vesting, settlement, and tax-withholding transactions, he holds 63,437 shares of Viatris common stock directly.
Viatris Inc director Dillon JoEllen Lyons reported equity compensation activity involving restricted stock units and common shares. On March 6, 2026, previously granted RSUs and related dividend equivalent units representing a total of 24,834.4921 units were exercised, delivering the same number of common shares as they vested in full.
On the same date, Lyons received a new grant of 15,890 RSUs, each representing one future share of Viatris common stock that will vest on March 6, 2027. Following these transactions, she directly holds 102,526 shares of common stock and indirectly holds an additional 18 shares through her spouse.
Viatris Inc director James M. Kilts reported compensation-related equity transactions with no share sales. On March 6, 2026 he exercised 23,660 restricted stock units and 1,174.4921 dividend equivalent units, receiving 24,834.4921 shares of common stock. He also received a new grant of 15,890 restricted stock units that will vest on March 6, 2027. Following these acquisitions, he directly holds 161,257 shares of common stock and 15,890 unvested restricted stock units. All activity reflects awards under the Viatris Inc. 2020 Stock Incentive Plan.
Viatris Inc director Vivaldi Coelho Rogerio reported equity compensation activity involving restricted stock units (RSUs) and related common shares. On March 6, 2026, previously granted RSUs representing 23,660 shares of common stock vested in full and were exercised, along with 1,174.4921 dividend equivalent units that had accrued on those RSUs. These derivative securities converted into common stock, leaving no remaining balance from those specific RSUs or dividend units.
On the same date, the director received a new grant of 15,890 RSUs, each representing one share of Viatris common stock, which will vest on March 6, 2027. Following these transactions, the filing shows 46,526 shares of common stock held directly and a separate outstanding RSU award of 15,890 units scheduled to vest in 2027. The activity reflects routine vesting and a new equity award rather than any open-market buying or selling.
DAMELIO FRANK A reported acquisition or exercise transactions in this Form 4 filing.
Viatris Inc director Frank A. Damelio reported routine equity compensation activity. On March 6, 2026, previously granted restricted stock units (RSUs), including related dividend equivalent units, were fully settled into 26,031 shares of common stock that he now holds directly.
On the same date, he also received a new grant of 15,890 RSUs, each representing one future share of Viatris common stock. According to the award terms, these new RSUs will vest on March 6, 2027, reflecting ongoing director compensation rather than open-market buying or selling.
Viatris Inc director W. Don Cornwell increased his equity stake through routine equity awards and vesting. On March 6, 2026 he exercised 23,660 restricted stock units and 1,174.4921 dividend equivalent units into 23,660 and 1,175 shares of common stock, respectively. He also received a new grant of 15,890 restricted stock units that will vest on March 6, 2027.
Following these transactions, he directly holds 112,044 shares of Viatris common stock and 15,890 restricted stock units, reflecting compensation-related activity rather than open-market buying or selling.
Viatris Inc director Elisha W. Finney reported equity compensation activity, not open-market trading. On March 6, 2026, Finney exercised restricted stock units and related dividend equivalent units, acquiring 24,834.4921 shares of Viatris common stock through derivative conversions.
After these settlements, Finney directly held 62,667 shares of common stock. On the same date, Finney also received a new grant of 15,890 restricted stock units under the Viatris Inc. 2020 Stock Incentive Plan, which will vest on March 6, 2027.
Viatris Inc Chief Financial Officer Theodora Mistras reported equity award activity tied to previously granted restricted stock units. On March 4, 2026, restricted stock units and related dividend equivalent units granted on March 4, 2024 vested and were converted into shares of common stock.
She acquired 31,149 shares of common stock from RSUs and 2,935 shares from dividend equivalent units through exercises at $0.00 per share, and had 17,226 and 1,624 shares of common stock withheld at $14.71 per share to cover tax liabilities. After these transactions, she held 51,076 shares of Viatris common stock directly.
Viatris Inc Chief Commercial Officer Corinne Le Goff reported vesting and settlement of equity awards, along with related tax withholdings. On March 4, 2026, 36,720 restricted stock units granted on April 18, 2024 vested and converted into common stock, as did 3,053 dividend equivalent units. To cover tax liabilities tied to these vestings, 16,300 and 1,355 shares of common stock were withheld at $14.71 per share rather than sold on the open market. After these transactions, she directly owned 57,417 shares of Viatris common stock.
Viatris Inc officer Andrew Enrietti reported multiple equity award transactions. On March 3, 2026, he received a grant of 110,630 Performance Restricted Stock Units (PRSUs) and exercised the same number of PRSUs into common stock at a price of $0.00 per share.
On March 3 and March 4, 2026, restricted stock units and dividend equivalent units previously granted in 2023 and 2024 vested and were converted into common stock at $0.00 per share, while several blocks of common shares were withheld at prices of $14.89 and $14.71 per share to cover tax liabilities. After these transactions, his directly held common stock position was 208,308 shares.
Viatris Inc officer Paul Campbell reported multiple equity compensation events involving restricted stock units, performance RSUs, dividend equivalent units, and common stock. On March 3, 2026, he received 169,718 performance RSUs, which vested the same day and were converted into common shares, along with vested RSUs and related dividend equivalents from prior grants.
Common shares delivered from these vestings were partly withheld to satisfy tax liabilities, including 74,320 shares at $14.8900 per share and other smaller withholdings at similar prices, as noted in the footnotes. After the March 4, 2026 transactions, Campbell directly held 371,353 shares of common stock, plus 318 shares held indirectly through a 401(k) plan.
Viatris Inc. chief executive officer Scott Andrew Smith reported multiple equity award transactions involving restricted stock units, performance restricted stock units, dividend equivalent units, and common stock. On March 3, 2026, he received 1,286,849 Performance Restricted Stock Units as a grant and then exercised the same number of PRSUs into common shares at a price of $0.00 per share.
That same day, he also converted 135,828 restricted stock units and 18,153.1987 dividend equivalent units into common stock, and common shares were disposed of at $14.89 per share to satisfy tax liabilities associated with these vestings, including 506,376 shares withheld. On March 4, 2026, additional RSUs and dividend equivalent units granted on March 4, 2024 converted into common stock, with share withholding transactions at $14.71 per share to cover related tax obligations. After these transactions, Smith continued to hold over one million shares of Viatris common stock directly.